Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jill Slansky

Concepts (330)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cancer Vaccines
14
2021
161
2.670
Why?
Receptors, Antigen, T-Cell
15
2023
673
2.460
Why?
CD8-Positive T-Lymphocytes
19
2024
919
2.300
Why?
Antigens, Neoplasm
13
2023
271
1.980
Why?
T-Lymphocytes
14
2023
1996
1.790
Why?
Neoplasms
13
2023
2906
1.750
Why?
Lymphocytes, Tumor-Infiltrating
5
2023
153
1.680
Why?
Vaccines, Subunit
4
2013
53
1.100
Why?
Peptides
8
2023
998
0.910
Why?
T-Lymphocytes, Cytotoxic
7
2022
177
0.900
Why?
Granzymes
2
2024
49
0.900
Why?
Epitopes, T-Lymphocyte
6
2012
174
0.870
Why?
Mice, Inbred BALB C
18
2021
1261
0.720
Why?
Leukemia
1
2024
246
0.690
Why?
Immunotherapy
8
2021
666
0.680
Why?
Lymphocyte Activation
11
2019
1132
0.670
Why?
Tumor Escape
3
2019
49
0.650
Why?
Tumor Microenvironment
8
2026
734
0.640
Why?
Baculoviridae
3
2009
44
0.620
Why?
Antigen Presentation
6
2018
207
0.610
Why?
Neoplasms, Experimental
2
2021
167
0.610
Why?
Immunogenetic Phenomena
1
2019
8
0.580
Why?
Immunomodulation
1
2020
99
0.580
Why?
Peptide Library
4
2013
91
0.580
Why?
Epitopes
2
2020
473
0.560
Why?
Insecta
3
2009
71
0.550
Why?
Animals
49
2026
38030
0.550
Why?
Histocompatibility Antigens Class I
6
2019
202
0.550
Why?
Major Histocompatibility Complex
4
2008
233
0.540
Why?
H-2 Antigens
5
2008
111
0.530
Why?
Mice
35
2026
18329
0.520
Why?
Breast Neoplasms
5
2026
2382
0.490
Why?
Alternative Splicing
1
2019
247
0.490
Why?
Gene Expression Regulation, Neoplastic
4
2019
1443
0.460
Why?
Autoimmunity
2
2020
933
0.440
Why?
Neoplasm Proteins
2
2018
441
0.430
Why?
Vaccines
2
2010
388
0.430
Why?
Immune Tolerance
3
2025
385
0.420
Why?
Up-Regulation
3
2019
847
0.420
Why?
Antigens
3
2019
348
0.420
Why?
Colorectal Neoplasms
5
2019
866
0.410
Why?
Cytotoxicity, Immunologic
6
2024
224
0.400
Why?
Colonic Neoplasms
3
2012
257
0.370
Why?
CD4-Positive T-Lymphocytes
3
2019
1140
0.370
Why?
Allergy and Immunology
1
2013
43
0.370
Why?
Complementarity Determining Regions
1
2012
54
0.360
Why?
B-Lymphocytes
1
2017
870
0.350
Why?
Antigenic Variation
1
2011
11
0.350
Why?
Moloney murine leukemia virus
1
2011
13
0.350
Why?
Viral Envelope Proteins
1
2011
98
0.330
Why?
Cell Cycle Proteins
6
1997
630
0.300
Why?
Carrier Proteins
6
1997
728
0.300
Why?
B7-H1 Antigen
2
2025
244
0.300
Why?
Histocompatibility Antigens
2
2020
102
0.300
Why?
DNA-Binding Proteins
9
2018
1480
0.290
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2022
334
0.280
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1189
0.270
Why?
Mice, Transgenic
6
2023
2188
0.270
Why?
Tetrahydrofolate Dehydrogenase
4
1997
22
0.270
Why?
Autoimmune Diseases
1
2012
468
0.260
Why?
Inflammation
4
2020
2878
0.250
Why?
Cross Reactions
2
2020
130
0.250
Why?
Cell Line, Tumor
11
2026
3542
0.250
Why?
Vaccination
3
2010
1426
0.240
Why?
Liver Neoplasms
4
2020
776
0.230
Why?
Nuclear Envelope
1
2026
45
0.230
Why?
Heme
1
2026
89
0.230
Why?
Lab-On-A-Chip Devices
1
2026
61
0.230
Why?
Triple Negative Breast Neoplasms
2
2019
218
0.230
Why?
Lung Neoplasms
2
2017
2664
0.220
Why?
Flow Cytometry
6
2016
1162
0.220
Why?
Humans
38
2026
145475
0.220
Why?
Histocompatibility Antigens Class II
2
2003
364
0.220
Why?
Semaphorins
1
2025
37
0.210
Why?
Mammary Glands, Animal
1
2025
128
0.210
Why?
Graft Rejection
2
2007
521
0.210
Why?
Transfection
2
2026
926
0.210
Why?
Antigens, CD
3
2025
558
0.200
Why?
Disease Models, Animal
3
2021
4560
0.200
Why?
Listeria monocytogenes
3
2011
102
0.190
Why?
Lymphocyte Count
4
2017
164
0.190
Why?
Models, Biological
1
2010
1764
0.190
Why?
Amino Acid Substitution
2
2020
302
0.180
Why?
Transcription Factors
6
1997
1734
0.180
Why?
DNA
4
2026
1435
0.170
Why?
Female
24
2026
78845
0.170
Why?
Base Sequence
7
2016
2170
0.170
Why?
Histocompatibility Antigen H-2D
4
2022
20
0.170
Why?
Dendritic Cells
3
2014
499
0.170
Why?
Aging
2
2011
1969
0.160
Why?
Receptor-CD3 Complex, Antigen, T-Cell
1
2000
9
0.160
Why?
Heterografts
1
2021
143
0.160
Why?
Cytoreduction Surgical Procedures
1
2020
69
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1963
0.150
Why?
Immune System
1
2021
180
0.150
Why?
Programmed Cell Death 1 Receptor
3
2019
265
0.150
Why?
Chemokines, CXC
1
2019
68
0.150
Why?
Bcl-2-Like Protein 11
1
2019
37
0.150
Why?
Nanotechnology
1
2020
114
0.150
Why?
Gene Editing
1
2020
89
0.140
Why?
Chemotherapy, Adjuvant
1
2020
423
0.140
Why?
Interleukin-12
1
2019
115
0.140
Why?
Oligopeptides
1
2000
267
0.140
Why?
Gene Transfer Techniques
1
2020
187
0.140
Why?
Calcineurin
1
2019
105
0.140
Why?
CRISPR-Cas Systems
1
2020
166
0.140
Why?
Mice, Knockout
5
2021
3124
0.140
Why?
Tryptophan Oxygenase
1
2018
33
0.140
Why?
Autoantigens
1
2021
427
0.140
Why?
Macrophages
1
2026
1507
0.140
Why?
Disease Susceptibility
1
2020
344
0.140
Why?
Mutation
5
2020
4075
0.140
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2019
89
0.130
Why?
Genetic Therapy
1
2020
316
0.130
Why?
Cell Line
2
2016
2823
0.130
Why?
Promoter Regions, Genetic
5
1997
1246
0.130
Why?
Neoadjuvant Therapy
1
2020
465
0.130
Why?
Histone Deacetylase Inhibitors
1
2019
218
0.130
Why?
Immunodominant Epitopes
2
2010
27
0.130
Why?
Antigen-Presenting Cells
1
2017
159
0.130
Why?
Genetic Engineering
2
2009
88
0.130
Why?
Tryptophan
1
2018
182
0.130
Why?
Transcriptional Activation
2
2018
372
0.120
Why?
Protein Tyrosine Phosphatases
1
2018
167
0.120
Why?
Oligonucleotide Array Sequence Analysis
2
2016
749
0.120
Why?
Antineoplastic Agents, Immunological
1
2019
198
0.120
Why?
Spodoptera
2
2021
40
0.120
Why?
Mononuclear Phagocyte System
1
2016
10
0.120
Why?
High-Throughput Nucleotide Sequencing
2
2017
530
0.120
Why?
Ligands
4
2018
665
0.120
Why?
Emulsions
1
2016
59
0.120
Why?
Immunophenotyping
1
2017
319
0.120
Why?
Sarcoidosis, Pulmonary
1
2017
98
0.120
Why?
Gene Expression Regulation
4
2022
2597
0.110
Why?
Lymph Nodes
2
2016
503
0.110
Why?
Phagocytes
1
2016
80
0.110
Why?
Cell Separation
1
2016
305
0.110
Why?
Papillomavirus Infections
1
2019
344
0.110
Why?
T-Lymphocyte Subsets
4
2007
418
0.110
Why?
Gene Expression Regulation, Enzymologic
2
1993
267
0.110
Why?
Lung
3
2017
4106
0.110
Why?
Bronchoalveolar Lavage Fluid
1
2017
638
0.110
Why?
Polymerase Chain Reaction
2
2016
1041
0.100
Why?
Interferon-gamma
5
2011
784
0.100
Why?
Retinoblastoma-Binding Protein 1
6
1997
22
0.100
Why?
Ovarian Neoplasms
1
2020
595
0.100
Why?
Head and Neck Neoplasms
1
2019
561
0.100
Why?
E2F Transcription Factors
6
1997
65
0.100
Why?
Transcription Factor DP1
5
1997
21
0.100
Why?
Gene Expression Profiling
2
2010
1767
0.090
Why?
Colorado
2
2013
4554
0.090
Why?
Prognosis
2
2020
4316
0.090
Why?
Molecular Sequence Data
8
2006
2883
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2012
848
0.090
Why?
T-Lymphocytes, Regulatory
3
2012
409
0.090
Why?
Transcription, Genetic
3
1997
1454
0.080
Why?
Hemangiosarcoma
1
2010
25
0.080
Why?
Lymphoma, B-Cell
1
2012
140
0.080
Why?
Universities
1
2013
445
0.080
Why?
Carcinoma
1
2011
225
0.080
Why?
Research
1
2013
430
0.080
Why?
Down-Regulation
1
2011
618
0.070
Why?
Genes, MHC Class I
1
2009
37
0.070
Why?
Neovascularization, Pathologic
1
2010
286
0.070
Why?
Mice, Inbred C57BL
5
2019
5983
0.070
Why?
Cross-Priming
1
2008
16
0.070
Why?
CD11c Antigen
1
2008
40
0.070
Why?
E2F1 Transcription Factor
4
1997
68
0.070
Why?
Adjuvants, Immunologic
1
2009
243
0.060
Why?
Protein Conformation
2
2003
938
0.060
Why?
Xenograft Model Antitumor Assays
2
2021
934
0.060
Why?
Cell Culture Techniques
1
2009
372
0.060
Why?
Intramolecular Oxidoreductases
1
2006
65
0.060
Why?
Biomarkers
1
2017
4295
0.060
Why?
Bilirubin
1
2026
99
0.060
Why?
Heme Oxygenase-1
1
2026
76
0.060
Why?
RNA, Messenger
2
1994
2803
0.060
Why?
Melanoma, Experimental
1
2006
109
0.060
Why?
Hematopoietic Stem Cell Transplantation
2
2021
699
0.060
Why?
DNA Primers
1
2006
505
0.060
Why?
Drug Design
1
2006
175
0.060
Why?
Plasmids
1
2026
373
0.050
Why?
Aged, 80 and over
1
2017
8333
0.050
Why?
Amino Acid Sequence
5
2018
2129
0.050
Why?
G1 Phase
2
1996
65
0.050
Why?
S Phase
2
1996
78
0.050
Why?
Male
8
2020
72843
0.050
Why?
Antigens, Surface
2
2001
155
0.050
Why?
Clone Cells
2
2003
263
0.050
Why?
Cells, Cultured
1
2011
4148
0.050
Why?
Mice, SCID
2
2021
369
0.050
Why?
Liver Neoplasms, Experimental
1
2003
26
0.050
Why?
3T3 Cells
4
2003
156
0.050
Why?
Genes, erbB-2
1
2003
32
0.050
Why?
Cell Survival
1
2026
1100
0.050
Why?
Mammary Neoplasms, Experimental
1
2003
62
0.050
Why?
Transplantation Chimera
1
2002
57
0.050
Why?
Germ Cells
1
2022
65
0.040
Why?
Molecular Conformation
1
2022
141
0.040
Why?
Interleukin-2
1
2003
440
0.040
Why?
Transglutaminases
1
2022
159
0.040
Why?
Sf9 Cells
1
2021
11
0.040
Why?
Middle Aged
3
2020
36215
0.040
Why?
Bone Marrow Cells
1
2002
321
0.040
Why?
B7-1 Antigen
1
2001
55
0.040
Why?
Chimerism
1
2021
35
0.040
Why?
Lymphocyte Subsets
1
2021
77
0.040
Why?
Lymphoid Tissue
1
2021
78
0.040
Why?
Immunoglobulins
1
2001
162
0.040
Why?
Surface Plasmon Resonance
1
2000
87
0.040
Why?
Aged
2
2017
26153
0.040
Why?
Recombinant Proteins
1
2003
1368
0.040
Why?
Dogs
2
2012
458
0.040
Why?
Alanine
1
2000
169
0.040
Why?
Mice, Inbred NOD
1
2021
613
0.040
Why?
Cyclophosphamide
2
2011
270
0.040
Why?
Skin Neoplasms
1
2006
849
0.040
Why?
Paraparesis, Tropical Spastic
1
1998
4
0.040
Why?
Models, Molecular
1
2003
1598
0.030
Why?
Gene Products, tax
1
1998
15
0.030
Why?
Gene Knockdown Techniques
1
2019
333
0.030
Why?
Lymphocytic Choriomeningitis
1
1998
25
0.030
Why?
Receptors, Tumor Necrosis Factor, Member 25
1
2017
5
0.030
Why?
Antibodies, Monoclonal
1
2025
1505
0.030
Why?
Kynurenine
1
2018
114
0.030
Why?
Combined Modality Therapy
1
2020
1266
0.030
Why?
Mice, Nude
1
2019
679
0.030
Why?
Antigens, Viral
1
1998
182
0.030
Why?
HLA-DRB1 Chains
1
2017
110
0.030
Why?
Drug Delivery Systems
1
2020
381
0.030
Why?
HLA Antigens
1
2018
240
0.030
Why?
Folic Acid Antagonists
1
1996
8
0.030
Why?
Sp1 Transcription Factor
1
1996
24
0.030
Why?
Enzyme Induction
1
1996
88
0.030
Why?
High-Throughput Screening Assays
1
2018
176
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
1996
92
0.030
Why?
Survival Rate
1
2020
2090
0.030
Why?
Gene Amplification
1
1996
118
0.030
Why?
Cadaver
1
2016
311
0.030
Why?
Clinical Trials as Topic
1
2020
1061
0.030
Why?
Integrin alpha Chains
1
2014
22
0.030
Why?
Interleukin-27
1
2014
13
0.030
Why?
Toll-Like Receptor 3
1
2014
30
0.030
Why?
Poly I-C
1
2014
58
0.030
Why?
CD11b Antigen
1
2014
60
0.030
Why?
Toll-Like Receptor 7
1
2014
43
0.030
Why?
Acute Disease
1
2017
1036
0.030
Why?
Cell Division
2
1993
756
0.030
Why?
DNA Replication
1
1996
249
0.030
Why?
Cell Cycle
2
1994
598
0.020
Why?
Culture Media, Serum-Free
1
1993
42
0.020
Why?
Nuclear Proteins
2
2001
740
0.020
Why?
Imidazoles
1
2014
247
0.020
Why?
Serum Response Factor
1
1993
33
0.020
Why?
Phenotype
1
2021
3155
0.020
Why?
Cloning, Molecular
3
2001
538
0.020
Why?
RNA Polymerase II
1
1996
350
0.020
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2003
161
0.020
Why?
Antineoplastic Agents
1
2003
2214
0.020
Why?
Membrane Glycoproteins
1
2014
499
0.020
Why?
Antigens, Differentiation
1
2011
76
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.020
Why?
Disease Progression
1
2019
2864
0.020
Why?
Cytokines
1
2019
2067
0.020
Why?
Dimerization
2
2001
189
0.020
Why?
CTLA-4 Antigen
1
2011
105
0.020
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
19
0.020
Why?
Follow-Up Studies
1
2020
5423
0.020
Why?
Proteomics
1
2018
1188
0.020
Why?
Statistics, Nonparametric
1
2011
428
0.020
Why?
Protein Biosynthesis
1
1993
452
0.020
Why?
ras Proteins
1
2010
150
0.020
Why?
Doxorubicin
1
2012
401
0.020
Why?
Analysis of Variance
1
2011
1300
0.020
Why?
Survival Analysis
1
2011
1374
0.020
Why?
Protein Binding
2
2006
2238
0.020
Why?
DNA, Complementary
2
2001
273
0.020
Why?
Vaccines, Attenuated
1
2007
129
0.020
Why?
Binding Sites
3
1997
1310
0.020
Why?
Peptide Fragments
2
2003
693
0.020
Why?
Injections, Intradermal
1
2006
11
0.020
Why?
Enterotoxins
1
2006
89
0.010
Why?
Neoplasm Transplantation
1
2006
246
0.010
Why?
Hepatitis
1
2006
43
0.010
Why?
Cell Adhesion
1
2006
451
0.010
Why?
Killer Cells, Natural
1
2007
480
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2003
39
0.010
Why?
Growth Inhibitors
1
2003
39
0.010
Why?
Vaccines, DNA
1
2003
32
0.010
Why?
Adult
2
2017
40777
0.010
Why?
Peptide Mapping
1
2003
62
0.010
Why?
Cell Line, Transformed
1
2003
138
0.010
Why?
Lymphocyte Culture Test, Mixed
1
2002
49
0.010
Why?
Injections, Intravenous
1
2003
197
0.010
Why?
Adoptive Transfer
1
2003
200
0.010
Why?
Mammary Neoplasms, Animal
1
2002
35
0.010
Why?
Drug Synergism
1
2003
354
0.010
Why?
Mice, Inbred DBA
1
2002
182
0.010
Why?
Mice, Inbred Strains
1
2003
396
0.010
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2001
10
0.010
Why?
Transplantation Immunology
1
2001
29
0.010
Why?
Programmed Cell Death 1 Ligand 2 Protein
1
2001
14
0.010
Why?
Transplantation, Homologous
1
2002
418
0.010
Why?
CD28 Antigens
1
2001
59
0.010
Why?
Tumor Cells, Cultured
1
2002
886
0.010
Why?
Gene Library
1
2001
122
0.010
Why?
Sequence Homology, Amino Acid
1
2001
387
0.010
Why?
Apoptosis Regulatory Proteins
1
2001
187
0.010
Why?
Graft vs Host Disease
1
2002
279
0.010
Why?
In Vitro Techniques
1
2001
1048
0.010
Why?
Genetic Vectors
1
2001
335
0.010
Why?
Image Cytometry
1
1998
11
0.010
Why?
HTLV-I Infections
1
1998
29
0.010
Why?
HLA-A2 Antigen
1
1998
36
0.010
Why?
Human T-lymphotropic virus 1
1
1998
32
0.010
Why?
Recombinant Fusion Proteins
1
2001
666
0.010
Why?
Protein-Tyrosine Kinases
1
2001
431
0.010
Why?
Immunity, Active
1
1998
8
0.010
Why?
E2F5 Transcription Factor
1
1997
2
0.010
Why?
E2F4 Transcription Factor
1
1997
6
0.010
Why?
Immunologic Memory
1
1998
368
0.010
Why?
HeLa Cells
1
1997
632
0.010
Why?
Proteins
1
2001
1023
0.010
Why?
Models, Genetic
1
1997
524
0.010
Why?
Rats
1
2003
5584
0.010
Why?
Genes
1
1994
227
0.010
Why?
Chromosome Mapping
1
1994
506
0.010
Why?
Molecular Weight
1
1992
312
0.010
Why?
Mutagenesis, Site-Directed
1
1992
376
0.010
Why?
Signal Transduction
1
2001
5216
0.000
Why?
Slansky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)